// App-Quantinova.ai

: A Mixed Methods Approach to Generate Meaningful Change Estimates for the EORTC QLQ-MY20

Researchers

Presenter

  • Emre Yucel

Principal Investigators

  • Andrew Trigg

  • Kate Sully

  • Amelia Harper

  • Nicola Bonner

  • Nina Shah

  • Sumeet Panjabi

  • Kim Cocks

Medical Centers

  • Amgen, Newbury Park, CA

  • Adelphi Values, Cheshire, United Kingdom

  • Adelphi Values, Bollington, United Kingdom

  • Parnassus Ave, 4th floor, University of California San Francisco, San Francisco, CA

  • University of California, San Francisco, San Francisco, CA

  • Amgen Inc, South San Francisco, CA

  • Adelphi Values, Bollington, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Peripheral Nervous System

Disease

  • Peripheral neuropathy

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • carfilzomib Intravenous

  • ZoMaxx

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved